(PharmaNewsWire.Com, April 16, 2019 ) According to research report the blood flow measurement devices market is projected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2%. The report analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global blood flow measurement devices market is segmented on the basis of product, application, and region. Based on product, the blood flow measurement devices market is categorized into ultrasound and laser Doppler. In 2016, the ultrasound segment commanded the largest share of the global blood flow measurement device market. This growth can be attributed to the growing applications of ultrasound products, such as vascular diseases and dermatology, and their usability in invasive as well as non-invasive applications. The ultrasound market is further categorized into ultrasound Doppler and transit-time flow meters (TTFM). In 2016, the ultrasound Doppler segment commanded the largest share of the global ultrasound market. The large share and high growth rate of these devices can be attributed to their growing applications, ease of use, and increased preference for non-invasive devices. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=243081818 Based on application, the blood flow measurement devices market is segmented into non-invasive applications and invasive applications. Non-invasive applications are further categorized into cardiovascular disease, diabetes, tumor monitoring, gastroenterology, and others applications (dermatology and intracranial pressure monitoring). The cardiovascular disease segment commanded the largest share of the global blood flow measurement device market, by non-invasive applications, in 2016. The large share and high growth rate of this segment can be attributed to the increasing prevalence of cardiovascular disease, rising geriatric population, and increasing focus of key market players on this market. Similarly, invasive applications are further segmented into coronary arterial bypass graft (CABG), microvascular surgery, and others (organ transplants and reconstructive surgery). The CABG segment commanded the largest share of the global blood flow measurement devices market in 2016. The growth in this segment can be attributed to a large number of CABG surgeries performed worldwide. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243081818 The key players in the blood flow measurement devices market include Cook Medical, Inc. (U.S.), Medistim ASA (Norway), Transonic Systems, Inc. (U.S.), ADInstruments (Australia), Moor Instruments Ltd. (U.K.), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), Compumedics Ltd. (Australia), Perimed AB (Sweden), and SONOTEC Ultraschallsensorik Halle GmbH (Germany).
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 newsletter@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
